About Qingxi Wang
Form D filings for Conjupro Biotherapeutics in 2023 list Qingxi Wang as CEO and director.
Qingxi Wang first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Qingxi Wang in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Qingxi Wang works with at each company, as listed on that company's latest Form D.
Conjupro Biotherapeutics Inc. · Form D, Sep 12, 2023
HW
Haixing Wang
Executive officer